As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilar and biologics will likely increase at 7.6% CAGR during the forecast period, taking the overall market valuation to a staggering USD 1,060.7 billion by 2034.

https://www.globenewswire.com/....en/news-release/2024